GIT2 Antikörper (AA 1-312)
Kurzübersicht für GIT2 Antikörper (AA 1-312) (ABIN1960173)
Target
Alle GIT2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-312
-
Spezifität
- Human GIT2
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Recombinant fragment corresponding to a region within amino acids 1 and 312 of GIT2 (SwissProt Q14161).
Type of Immunogen: Recombinant protein -
Isotyp
- IgG
-
-
anti-G Protein-Coupled Receptor Kinase Interactor 2 (GIT2) (AA 1-471) antibody
GIT2 Reaktivität: Human WB, ELISA, IF, IHC (p) Wirt: Maus Monoclonal 3B5-B9 unconjugated
anti-G Protein-Coupled Receptor Kinase Interactor 2 (GIT2) (AA 1-471) antibodyGIT2 Reaktivität: Human WB, ELISA, IF, IP Wirt: Maus Monoclonal M1 unconjugated
anti-G Protein-Coupled Receptor Kinase Interactor 2 (GIT2) (AA 1-471) antibodyGIT2 Reaktivität: Human WB, FACS Wirt: Maus Polyclonal unconjugated
anti-G Protein-Coupled Receptor Kinase Interactor 2 (GIT2) (Internal Region) antibodyGIT2 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-G Protein-Coupled Receptor Kinase Interactor 2 (GIT2) (AA 1-603) antibodyGIT2 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-G Protein-Coupled Receptor Kinase Interactor 2 (GIT2) (Internal Region) antibodyGIT2 Reaktivität: Human, Maus, Ratte WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-G Protein-Coupled Receptor Kinase Interactor 2 (GIT2) (AA 1-471) antibodyGIT2 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-G Protein-Coupled Receptor Kinase Interactor 2 (GIT2) (AA 401-498) antibodyGIT2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1B2 unconjugated
anti-G Protein-Coupled Receptor Kinase Interactor 2 (GIT2) (AA 450-510) antibodyGIT2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-G Protein-Coupled Receptor Kinase Interactor 2 (GIT2) (AA 714-749), (C-Term) antibodyGIT2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB48356 unconjugated
-
-
Applikationshinweise
-
Approved: ICC (1:100 - 1:1000), IHC, IHC-P (7.5 μg/mL), WB (1:500 - 1:3000)
Usage: Suggested starting dilutions are as follows: Western blot: 1:500-1:3000, ICC/IF: 1,100-1:1000, IHC-Paraffin: 7.5 μg/mL. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.1 M Tris-glycine, pH 7, 20 % Glycerol, 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and freeze at -20°C. Avoid freeze-thaw cycles.
-
-
- GIT2 (G Protein-Coupled Receptor Kinase Interactor 2 (GIT2))
-
Andere Bezeichnung
- GIT2
-
Hintergrund
-
Name/Gene ID: GIT2
Synonyms: GIT2, CAT2, KIAA0148, GRK-interacting protein 2, ARF GAP GIT2, CAT-2 -
Gen-ID
- 9815
-
Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling
Target
-
